STRATEGIC INSIGHTS FOR YOUR CLINICAL TRIAL

Enhance your trial strategy with global data insights

Advance your clinical strategy by harnessing global data insights to support early study planning. IQVIA’s expansive analytics, proven AI/ML and unparallelled domain knowledge empower you to identify the ideal mix of countries and sites before your trial goes live, accelerating site selection and activation. This informed approach allows you to assess study viability before launch, streamlining your enrollment strategy and minimizing operational risk.

Solutions Research & Development Consulting Clinical Trial Planning

Trial Strategy

AI-powered study planning and clinical trial feasibility for all stages

IQVIA’s global data assets, including real-world data, can be applied to give you a comprehensive view of the competitive landscape, patient availability, enrollment rate analysis and optimal countries for your study. Our proprietary AI-driven technology enables our expert recommendations, helping you assess study feasibility and enrollment potential. These insights ensure your study has the best possible chance of being on time, on budget and attaining high-quality data.

AI-powered analytics and custom strategies position your study for operational success:

Enrollment strategies

Country and site analysis combined with enrollment rate information enable enrollment strategies to be optimized for a study timelines by:

Adjusting the country mix
Adding more sites
Understanding investigator willingness to participate

Site analysis

Once study-specific countries have been identified, AI helps determine the number of sites needed per country to meet the study’s requirements. Sites are assessed on:

Trial experience and past performance
Study-specific eligibility criteria
Real-world treatment paths and patient journeys
Patient availability and recruitment potential

Country analysis

Country analysis provides sponsors with an optimal country mix. Targeted countries are based on an evaluation of:

Disease prevalence
Standard of care
Regulatory requirements
Marketing requirements
Competitive trials
Historical recruitment rates
Number of sites that have enrolled patients in similar studies

Site Insights

Global Site Insights for enhanced site selection

Understand the prevalence of an indication by country, city and site to determine patient availability for your clinical program or study with global patient density insights. These data-informed insights allow you to make key decisions about your site strategy with site and investigator data based on the volume of treated patients within a given indication. In addition to informing your site selection, Site Insights can be leveraged to ensure representative recruitment practices. With this knowledge, you can expedite your study planning prior to operationalization.

Leverage unparalleled global data to answer key questions:

Develop your site list with curated data that includes patient volume, site and physician experience and competition

Layer key opinion leader expertise into your site selection process to identify investigators to represent your study

Link race and ethnicity data to patient density data and/or geographical survey data to inform your site selection

Hub and Proximity Networks help you build referral networks for potential sites to address potential recruitment head on

Study-specific analytics aggregate lab biomarkers and patient density data to help you identify facilities that have screened patients for a specific indication or lab test

LET’S TALK

Optimize your study with AI/ML and applied data

Early planning with evidence-based recommendations sets your study up for success. From assessing study feasibility to support protocol development through supporting ongoing studies, we help ensure you have the best mix of countries and sites to support your protocol objective and timeline.

Get in touch